Literature DB >> 17055829

Intravenous immunoglobulin (IVIG) and recurrent spontaneous pregnancy loss.

.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17055829     DOI： 10.1016/j.fertnstert.2006.08.047

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  4 in total

Review 1.  Local and systemic factors and implantation: what is the evidence?

Authors:  Chelsea Fox; Scott Morin; Jae-Wook Jeong; Richard T Scott; Bruce A Lessey
Journal:  Fertil Steril       Date:  2016-03-03       Impact factor: 7.329

Review 2.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

3.  A high dose intravenous immunoglobulin therapy for women with four or more recurrent spontaneous abortions.

Authors:  Hideto Yamada; Masamitsu Takeda; Yoko Maezawa; Yasuhiko Ebina; Ryoichi Hazama; Kenji Tanimura; Yukio Wakui; Shigeki Shimada
Journal:  ISRN Obstet Gynecol       Date:  2012-09-11

4.  Evaluating the Utility of Intralipid Infusion to Improve Live Birth Rates in Patients with Recurrent Pregnancy Loss or Recurrent Implantation Failure.

Authors:  Anne E Martini; Sue Jasulaitis; Louis F Fogg; Meike L Uhler; Jennifer E Hirshfeld-Cytron
Journal:  J Hum Reprod Sci       Date:  2018 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.